About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4429667
Allelic
Composition
Drd2tm1Low/Drd2tm1Low
Genetic
Background
B6.129S2-Drd2tm1Low
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Drd2tm1Low mutation (1 available); any Drd2 mutation (70 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
N
• mice exhibit a normal saccharin and quinine preference and locomotor depressant response to SCH-23390 treatment (J:50787)
• mice exhibit normal basic motor skills without tremor, ataxia, or abnormal stance or posture (J:103181)
• mice exhibit normal novel odor habituation and odor sensitivity (J:110704)
• mice exhibit normal tactile responsivity, trigeminal nerve response, or aversive taste reactivity (J:110704)
• preference ratio is less than 0.4
• mice consume less 6% and 10% ethanol solution compared with wild-type mice
• amphetamine-treated mice fail to exhibit a reduction in prepulse inhibition unlike similarly treated wild-type mice
• however, amphetamine-treated mice exhibit normal reduction in startle reactivity
• ethanol-treated mice fail to exhibit a locomotor depressant responses unlike similarly treated wild-type mice
• ethanol-treated mice exhibit reduced ataxic response compared with similarly treated wild-type mice
• during reversal learning trials, mice preserve unreinforced behavior and commit more reversal errors across reversal sessions compared with wild-type mice
• mice exhibit reduced performance in an odor-driven stimulus-discrimination, operant task compared with wild-type mice
• mice fail to exhibit an increase in investigation of a novel odor unlike wild-type mice
• mice exhibit an impairment in olfactory discrimination compared with wild-type mice
• mice fail to exhibit increased investigation of an object with a novel scent versus one with s familiar scent unlike wild-type mice
• however, mice exhibit normal exploration behavior
• mice exhibit reduced acoustic startle response amplitude compared with wild-type mice
• on days 2 and 3, but not 4, of a rotarod test
• mice exhibit decreased horizontal distance, initiation of movement, rearing, and duration of horizontal movement compared with C57BL/6 mice (J:47001)
• mice exhibit reduced mean distance, number of movements, and time in motion compared with wild-type mice (J:50787)
• however, the movement speed and movement length are normal (J:50787)
• ethanol-treated mice exhibit reduced ataxic response compared with similarly treated wild-type mice
• mice exhibit reduced initiation of movement compared with C57BL/6 mice (J:47001)
• mice exhibit decreased initiation of movement compared with wild-type mice (J:103181)

nervous system
• mice fail to exhibit an increase in paired pulse ratio during development unlike wild-type mice
• mice fail to exhibit an increase in paired pulse ratio during development unlike wild-type mice
• mice subjected to high-frequency stimulation fail to exhibit a change in paired pulse ratio unlike similarly treated wild-type mice
• mice fail to exhibit a decrease in the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) during development unlike wild-type mice
• at P21 to 27, mice exhibit increased spontaneous postsynaptic current compared with wild-type mice
• amphetamine-treated mice fail to exhibit a reduction in prepulse inhibition unlike similarly treated wild-type mice
• at P22 to 27, striatal long term depression cannot be induced by high-frequency stimulation unlike in wild-type mice

respiratory system
• under hypercapnic conditions in male, but not female, mice
• under hypoxic hypercapnic conditions in female, but not male mice
• under hypoxic hypercapnic conditions in female, but not male mice
• in male mice at day 2 and 8 of exposure to poikilocapnic hypoxia
• under hypoxic conditions in female, but not male mice
• under hypercapnic conditions in male, but not female, mice
• under hypoxic hypercapnic conditions in female, but not male mice
• at low levels of hypoxia in male mice

cardiovascular system
• mice exhibit increased blood pressure compared with wild-type mice
• during the first 5 minutes after AT1 antagonist treatment, mice exhibit a greater decrease in blood pressure than similarly treated wild-type mice
• phentolamine-treated mice exhibit a greater decrease in blood pressure than similarly treated wild-type mice
• BQ-788-treated mice exhibit a decrease in blood pressure unlike in similarly treated wild-type mice
• RES-701-1-treated mice exhibit a greater increase in blood pressure than similarly treated wild-type mice
• sarafotoxin S6c-treated mice exhibit a greater increase in blood pressure than similarly treated wild-type mice
• however, acute adrenalectomy results in normal blood pressure compared with similarly treated wild-type mice

homeostasis/metabolism
• before and after saline loading
• sarafotoxin S6c-treated mice exhibit a greater increase in blood pressure than similarly treated wild-type mice
• during the first 5 minutes after AT1 antagonist treatment, mice exhibit a greater decrease in blood pressure than similarly treated wild-type mice
• phentolamine-treated mice exhibit a greater decrease in blood pressure than similarly treated wild-type mice
• BQ-788-treated mice exhibit a decrease in blood pressure unlike in similarly treated wild-type mice
• RES-701-1-treated mice exhibit a greater increase in blood pressure than similarly treated wild-type mice
• however, mice respond normally to treatment with an ET(A) or V1 vasopressin receptor antagonist

renal/urinary system
• before and after saline loading
• before and after saline loading

growth/size/body
• in male, but not female, mice

taste/olfaction
N
• mice exhibit normal novel odor habituation and odor sensitivity

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
NOT Parkinson's disease DOID:14330 OMIM:PS168600
J:47001


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/12/2024
MGI 6.23
The Jackson Laboratory